Paal Fr Brunsvig
Overview
Explore the profile of Paal Fr Brunsvig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
196
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ardizzoni A, Tiseo M, Boni L, Di Maio M, Buffoni L, Belvedere O, et al.
Lung Cancer
. 2016 Sep;
100:30-37.
PMID: 27597278
Background: Chemo-radiotherapy is standard of care in the treatment of unresectable stage III NSCLC. We aimed at assessing whether the addition of concurrent taxane-chemotherapy to thoracic irradiation following chemotherapy was...
2.
Brunsvig P, Kyte J, Kersten C, Sundstrom S, Moller M, Nyakas M, et al.
Clin Cancer Res
. 2011 Sep;
17(21):6847-57.
PMID: 21918169
Purpose: We report two clinical trials in non-small cell lung cancer (NSCLC) patients evaluating immune response, toxicity, and clinical outcome after vaccination with the telomerase peptide GV1001: a phase II...
3.
Gronberg B, Bremnes R, Flotten O, Amundsen T, Brunsvig P, Hjelde H, et al.
J Clin Oncol
. 2009 May;
27(19):3217-24.
PMID: 19433683
PURPOSE To compare pemetrexed/carboplatin with a standard regimen as first-line therapy in advanced non-small-cell lung cancer NSCLC. PATIENTS AND METHODS Patients with stage IIIB or IV NSCLC and performance status...
4.
Helbekkmo N, Aasebo U, Sundstrom S, von Plessen C, Brunsvig P, Bremnes R
Lung Cancer
. 2008 Apr;
62(2):253-60.
PMID: 18417246
Background: There is no consensus regarding chemotherapy to patients with advanced NSCLC (ANSCLC) and performance status (PS) 2. Using data from a national multicenter study comparing two third-generation carboplatin-based regimens...
5.
Brunsvig P, Flatmark K, Aamdal S, Hoifodt H, Le H, Jakobsen E, et al.
Lung Cancer
. 2008 Feb;
61(2):170-6.
PMID: 18261824
Background: The clinical relevance of bone marrow micrometastases in non-small cell lung cancer (NSCLC) is undetermined, and the value of such analyses in advanced stage patients has not been assessed...